LORKETTA Trademark

Trademark Overview


On Monday, October 2, 2023, a trademark application was filed for LORKETTA with the United States Patent and Trademark Office. The USPTO has given the LORKETTA trademark a serial number of 79384567. The federal status of this trademark filing is PUBLICATION/ISSUE REVIEW COMPLETE as of Thursday, June 13, 2024. This trademark is owned by Novartis AG. The LORKETTA trademark is filed in the Pharmaceutical Products category with the following description:

Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the p...
lorketta

General Information


Serial Number79384567
Word MarkLORKETTA
Filing DateMonday, October 2, 2023
Status681 - PUBLICATION/ISSUE REVIEW COMPLETE
Status DateThursday, June 13, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 16, 2024

Trademark Statements


Goods and ServicesAnti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, December 15, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameNovartis AG
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressCH

Trademark Events


Event DateEvent Description
Tuesday, December 19, 2023APPLICATION FILING RECEIPT MAILED
Thursday, December 7, 2023SN ASSIGNED FOR SECT 66A APPL FROM IB
Thursday, December 14, 2023LIMITATION FROM ORIGINAL APPLICATION ENTERED
Friday, December 15, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, January 2, 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, January 2, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, January 2, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, January 2, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, January 2, 2024TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Tuesday, January 2, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, January 23, 2024NON-FINAL ACTION WRITTEN
Thursday, January 18, 2024ASSIGNED TO EXAMINER
Wednesday, January 24, 2024NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Friday, February 9, 2024NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Friday, February 9, 2024REFUSAL PROCESSED BY MPU
Friday, June 7, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, June 7, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, June 7, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, June 12, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, June 26, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, March 5, 2024REFUSAL PROCESSED BY IB